SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-037380
Filing Date
2023-02-14
Accepted
2023-02-14 08:22:58
Documents
1
Group Members
GUY LEVYSOLEUS CAPITAL GROUP, LLCSOLEUS CAPITAL, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d458587dsc13ga.htm SC 13G/A 88340
  Complete submission text file 0001193125-23-037380.txt   90029
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Subject) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89667 | Film No.: 23622776
SIC: 2834 Pharmaceutical Preparations

Mailing Address 104 FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830
Business Address 104 FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830 4752083111
Soleus Capital Master Fund, L.P. (Filed by) CIK: 0001812275 (see all company filings)

IRS No.: 981413657 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A